A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) (Q63578322)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) |
clinical trial |
Statements
SLE-BRAVE-X (English)
0 references
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE) (English)
0 references
30 August 2019
0 references
1 February 2024
0 references
1,100
0 references
18 year
0 references